Clorox price target lowered to $96 from $110 at UBS

UBS lowered the firm’s price target on Clorox (CLX) to $96 from $110 and keeps a Neutral rating on the shares. Clorox beat Q3 EPS expectations on lower SG&A but significantly cut FY26 guidance, surprising investors with the magnitude of the reduction and highlighting continued delays in organic sales improvement and limited visibility into medium-term earnings, leading to a cautious outlook despite an attractive valuation, the analyst says in a research note.